The annual conference and exhibition aims to accelerate and improve biopharmaceutical processes and product development, attracting key personnel from across the bioprocessing industry. At this year's event Novozymes' booth will feature the company's range of regulatory compliant, recombinant and animal-free products and technologies.
During the five day conference, Novozymes will be presenting two technical posters entitled "Albumin: A robust pharmaceutical excipient in the stabilization of protein therapeutics' and "Application of animal-free recombinant bioactive protein supplements to improve the performance of cell-based viral vaccine production". In addition the company will deliver a presentation on the "Impact of recombinant albumin on the stability of a malarial antigen vaccine".
Novozymes will also be hosting a workshop on "Improving biomanufacturing efficiency through recombinant solutions". Company experts will discuss how the introduction of innovative technologies and products and ongoing collaborative dialogue with the biomanufacturing industry are driving efficiency improvements across the biopharmaceutical lifecycle.
Novozymes
Novozymes
